HUTCHMED (China) (HCM) Depreciation & Amortization (CF) (2015 - 2016)

HUTCHMED (China) (HCM) reported Depreciation & Amortization (CF) of -$1.5 million for Q2 2016, down 182.84% year-over-year from $1.8 million in Q3 2015, and down 182.84% quarter-over-quarter from $1.8 million in Q2 2015.

HUTCHMED (China) (HCM) Depreciation & Amortization (CF) (2015 - 2016) Analysis & Trends

HUTCHMED (China) (HCM) has 2 years of Depreciation & Amortization (CF) data on file, last reported at -$1.5 million in Q2 2016.

  • Depreciation & Amortization (CF) for Q2 2016 came in at -$1.5 million, down 182.84% year-over-year; the trailing twelve-month figure through Dec 2017 was -$1.5 million (down 582.69% YoY), and the FY2025 annual result was $13.3 million, up 7.84% from the prior year.
  • Depreciation & Amortization (CF) slipped to -$1.5 million in Q2 2016 per HCM's latest filing, from $1.8 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $1.8 million in Q2 2015 and troughed at -$1.5 million in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 239.00 Mn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 22.60 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 7.20 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 19.43 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 22.68 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 497,000.00
10 HUTCHMED (China) 1.21 Bn -261.65 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2016 -1.51 Mn
Jun 30, 2016 -1.51 Mn
Jun 30, 2015 1.82 Mn
Jun 30, 2015 1.82 Mn